Complications with the implant used to treat blood vessel dissection after balloon angioplasty or stent placement can result ...

Philips has recommended that customers immediately stop using affected Tack endovascular systems and return unused product to the company.

USA TODAY has reached out to the attorneys for comment. Philips announced a recall for millions of their Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP ...

Exor NV , the investment arm of Italy's Agnelli family, has increased its stake in health technology company Philips to 18.7% ...

The FDA advised this week that Philips is recalling the Tack endovascular systems because of challenges experienced by customers d ...

Philips is pulling from the market an implant designed to help repair the interior of damaged blood vessels following a serious product recall. The company’s Tack endovascular system includes a ...

Philips is recalling the Tack endovascular system because of what it says are user challenges that have led to additional interventions needed to retrieve or remove the implant. The US Food and Drug ...

During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines.

Philips has posted 33.6% higher losses for 2024 compared to 2023 as the company continues to battle weaker demand in China and settlements for its faulty sleep apnoea devices. Philips reported ...

Philips will no longer sell its Tack endovascular system in the US following a Class I recall by the US Food and Drug Administration (FDA). Class I is the most serious designation for a recall ...